BioMarin to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5 at 4:30pm ET

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host a conference call and webcast on November 5, 2020, at 4:30 p.m. ET to discuss its third quarter 2020 financial results and provide a business update.

Rhea-AI Summary

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host a conference call and webcast on November 5, 2020, at 4:30 p.m. ET to discuss its third quarter 2020 financial results and provide a business update. The call can be accessed via U.S. and international dial-in numbers, with a conference ID of 3291898. A replay will be available for one week after the call. BioMarin focuses on innovative therapies for serious rare genetic diseases, offering six commercial products and various clinical candidates.

Positive

• N/A

Negative

• N/A

Argus Session date unavailable

+2.15% session move Open Argus

Details

News Market Reaction – BMRN

The recorded move for BMRN in the trading session of this news was +2.15%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN RAFAEL, Calif., Oct. 22, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, November 5, at 4:30 p.m. ET to discuss third quarter 2020 financial results and provide a general business update.

Dial-in Number 
U.S. / Canada Dial-in Number: (866) 502-9859
International Dial-in Number: (574) 990-1362
Conference ID: 3291898

Replay Dial-in Number: (855) 859-2056
Replay International Dial-in Number: (404) 537-3406
Conference ID: 3291898

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-host-third-quarter-2020-financial-results-conference-call-and-webcast-on-thursday-november-5-at-430pm-et-301157647.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will BioMarin report its third quarter 2020 financial results?

BioMarin will report its third quarter 2020 financial results on November 5, 2020.

How can I listen to BioMarin's conference call?

You can listen to BioMarin's conference call via a live audio webcast on their investor website.

Is there a replay available for BioMarin's conference call?

Yes, a replay of the conference call will be available for one week following the call.

What is the conference ID for BioMarin's upcoming call?

The conference ID for BioMarin's upcoming call is 3291898.

What is the focus of BioMarin Pharmaceutical?

BioMarin is focused on developing therapies for serious and life-threatening rare genetic diseases.